Literature DB >> 18259842

Cdc6 knockdown inhibits human neuroblastoma cell proliferation.

Luo Feng1, Jerry R Barnhart, Robert C Seeger, Lingtao Wu, Nino Keshelava, Sheng-He Huang, Ambrose Jong.   

Abstract

The cell division controller Cdc6 plays a central role in the initiation of DNA replication. It was found that elevated levels of Cdc6 were present in many of human cancer cells, and the accumulation of Cdc6 is required for cell proliferation. In this study, we have investigated the control of Cdc6 expression and its effect on cell proliferation and death in human neuroblastoma cells. Elevated levels of Cdc6 are found in the LA-N-2, CHLA255, and other cell lines that grow fast. Cdc6 knockdown via a Cdc6 short hairpin RNA lentivirus causes the accumulation of sub-G1 populations with the decrease of S contents in the LA-N-2 and CHLA255 cells. Expression profile from the selected genes shows the reduction of cyclin E, cyclin A, and Cdc25C, with a boosted increase of the CDK inhibitor p27Kip1, indicating the suppression of tumor cell proliferation. Further, Cdc6 knockdown causes the increase of pro-apoptotic Bax accompanied with the decrease of anti-apoptotic Bcl-2, resulting in the increased cell death. Furthermore, Cdc6 knockdown causes a sharp reduction of tumor suppressor protein p53, and Cdc6 overexpression renders a boosted p53 expression; and this regulation is at p53 posttranscriptional level. Our study indicates that human Cdc6 functions in several pathways to control the cell proliferation and the cell death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18259842     DOI: 10.1007/s11010-008-9709-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA.

Authors:  Pierre-François Cartron; Tristan Gallenne; Gwenola Bougras; Fabien Gautier; Florence Manero; Patricia Vusio; Khaled Meflah; François M Vallette; Philippe Juin
Journal:  Mol Cell       Date:  2004-12-03       Impact factor: 17.970

2.  CDKs promote DNA replication origin licensing in human cells by protecting Cdc6 from APC/C-dependent proteolysis.

Authors:  Niels Mailand; John F X Diffley
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

3.  Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2.

Authors:  K Sadhu; S I Reed; H Richardson; P Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 4.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

5.  Oncogenic activity of Cdc6 through repression of the INK4/ARF locus.

Authors:  Susana Gonzalez; Peter Klatt; Sonia Delgado; Esther Conde; Fernando Lopez-Rios; Montserrat Sanchez-Cespedes; Juan Mendez; Francisco Antequera; Manuel Serrano
Journal:  Nature       Date:  2006-03-30       Impact factor: 49.962

6.  RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells.

Authors:  Feng Jiang; Nancy P Caraway; RuiYun Li; Ruth L Katz
Journal:  Oncogene       Date:  2005-05-12       Impact factor: 9.867

7.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.

Authors:  Vassilis G Gorgoulis; Leandros-Vassilios F Vassiliou; Panagiotis Karakaidos; Panayotis Zacharatos; Athanassios Kotsinas; Triantafillos Liloglou; Monica Venere; Richard A Ditullio; Nikolaos G Kastrinakis; Brynn Levy; Dimitris Kletsas; Akihiro Yoneta; Meenhard Herlyn; Christos Kittas; Thanos D Halazonetis
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

8.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

Review 9.  Downregulation of human Cdc6 protein using a lentivirus RNA interference expression vector.

Authors:  Feng Luo; Jiing-Kuan Yee; Sheng-He Huang; Ling-Tao Wu; Ambrose Y Jong
Journal:  Methods Mol Biol       Date:  2006

10.  A p53-dependent checkpoint pathway prevents rereplication.

Authors:  Cyrus Vaziri; Sandeep Saxena; Yesu Jeon; Charles Lee; Kazutaka Murata; Yuichi Machida; Nikhil Wagle; Deog Su Hwang; Anindya Dutta
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

View more
  4 in total

1.  Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma.

Authors:  Presha Rajbhandari; Gonzalo Lopez; Claudia Capdevila; Beatrice Salvatori; Jiyang Yu; Ruth Rodriguez-Barrueco; Daniel Martinez; Mark Yarmarkovich; Nina Weichert-Leahey; Brian J Abraham; Mariano J Alvarez; Archana Iyer; Jo Lynne Harenza; Derek Oldridge; Katleen De Preter; Jan Koster; Shahab Asgharzadeh; Robert C Seeger; Jun S Wei; Javed Khan; Jo Vandesompele; Pieter Mestdagh; Rogier Versteeg; A Thomas Look; Richard A Young; Antonio Iavarone; Anna Lasorella; Jose M Silva; John M Maris; Andrea Califano
Journal:  Cancer Discov       Date:  2018-03-06       Impact factor: 39.397

2.  Identification of genes and pathways in nasopharyngeal carcinoma by bioinformatics analysis.

Authors:  Fang Chen; Congxiang Shen; Xiaoqi Wang; Huigang Wang; Yanhui Liu; Chaosheng Yu; Jieyu Lv; Jingjing He; Zhong Wen
Journal:  Oncotarget       Date:  2017-07-22

3.  Importance of gene expression signatures in pancreatic cancer prognosis and the establishment of a prediction model.

Authors:  Xiaokai Yan; Haifeng Wan; Xiangyong Hao; Tian Lan; Wei Li; Lin Xu; Kefei Yuan; Hong Wu
Journal:  Cancer Manag Res       Date:  2018-12-27       Impact factor: 3.989

4.  Cdc6 disruption leads to centrosome abnormalities and chromosome instability in pancreatic cancer cells.

Authors:  Yuna Youn; Jong-Chan Lee; Jaihwan Kim; Jae Hyeong Kim; Jin-Hyeok Hwang
Journal:  Sci Rep       Date:  2020-10-05       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.